Two Sigma Advisers’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Buy |
37,480
+27,152
| +263% | +$201K | ﹤0.01% | 1996 |
|
|
2025
Q1 | $88.9K | Sell |
10,328
-7,592
| -42% | -$65.3K | ﹤0.01% | 2255 |
|
|
2024
Q4 | $641K | Sell |
17,920
-1,552
| -8% | -$55.5K | ﹤0.01% | 1675 |
|
|
2024
Q3 | $920K | Sell |
19,472
-9,300
| -32% | -$439K | ﹤0.01% | 1452 |
|
|
2024
Q2 | $1.45M | Buy |
28,772
+22,540
| +362% | +$1.13M | ﹤0.01% | 1371 |
|
|
2024
Q1 | $698K | Buy |
6,232
+176
| +3% | +$19.7K | ﹤0.01% | 1729 |
|
|
2023
Q4 | $351K | Sell |
6,056
-8,372
| -58% | -$486K | ﹤0.01% | 2053 |
|
|
2023
Q3 | $458K | Sell |
14,428
-8,696
| -38% | -$276K | ﹤0.01% | 1822 |
|
|
2023
Q2 | $1.9M | Sell |
23,124
-9,056
| -28% | -$745K | ﹤0.01% | 1226 |
|
|
2023
Q1 | $3.31M | Sell |
32,180
-9,952
| -24% | -$1.02M | 0.01% | 1004 |
|
|
2022
Q4 | $6.17M | Sell |
42,132
-2,576
| -6% | -$377K | 0.02% | 696 |
|
|
2022
Q3 | $7.56M | Buy |
44,708
+1,240
| +3% | +$210K | 0.02% | 579 |
|
|
2022
Q2 | $5.02M | Sell |
43,468
-10,512
| -19% | -$1.21M | 0.01% | 775 |
|
|
2022
Q1 | $5.39M | Buy |
53,980
+11,972
| +28% | +$1.19M | 0.01% | 772 |
|
|
2021
Q4 | $6.53M | Buy |
42,008
+16,808
| +67% | +$2.61M | 0.02% | 655 |
|
|
2021
Q3 | $5.94M | Buy |
25,200
+2,496
| +11% | +$588K | 0.02% | 708 |
|
|
2021
Q2 | $7.71M | Sell |
22,704
-764
| -3% | -$259K | 0.02% | 662 |
|
|
2021
Q1 | $9.49M | Buy |
23,468
+3,872
| +20% | +$1.57M | 0.03% | 592 |
|
|
2020
Q4 | $13M | Buy |
19,596
+7,816
| +66% | +$5.2M | 0.03% | 479 |
|
|
2020
Q3 | $5.48M | Buy |
11,780
+6,916
| +142% | +$3.22M | 0.02% | 736 |
|
|
2020
Q2 | $2.85M | Buy |
4,864
+2,804
| +136% | +$1.64M | 0.01% | 1031 |
|
|
2020
Q1 | $300K | Buy |
2,060
+564
| +38% | +$82.1K | ﹤0.01% | 2012 |
|
|
2019
Q4 | $214K | Buy |
1,496
+60
| +4% | +$8.58K | ﹤0.01% | 2161 |
|
|
2019
Q3 | $57K | Buy |
1,436
+976
| +212% | +$38.7K | ﹤0.01% | 2148 |
|
|
2019
Q2 | $47K | Buy |
+460
| New | +$47K | ﹤0.01% | 2257 |
|